TriSalus Life Sciences, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:TLSI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 28.63 M41.32 M36.46 M35.33 M70.98 M Total liabilities 62.99 M60.74 M63.19 M69.19 M58.17 M Total equity -34.37 M-19.42 M-26.73 M-33.86 M12.81 M Total liabilities & shareholders' equities 28.63 M41.32 M36.46 M35.33 M70.98 M Total debt 31.7 M32.27 M32.76 M33.05 M33.08 M Net debt 31.7 M32.27 M32.76 M33.05 M33.08 M

News

QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last?

TriSalus Life Sciences, Inc. (TLSI) Q1 2026 Earnings Call Transcript

TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates

VAREX IMAGING (VREX) Q2 Earnings and Revenues Miss Estimates

Jones Trading reiterates Buy on TriSalus Life Sciences stock after earnings

TriSalus Life Sciences, Inc. (TLSI) Q4 2025 Earnings Call Transcript

Earnings call transcript: TriSalus Life Sciences sees 60% Q4 revenue rise

TriSalus prices $40M public offering at $4.10 per share

TriSalus Life Sciences appoints Michael Stansky to board of directors

TriSalus Life Sciences, Inc. (TLSI) Upgraded to Buy: Here's What You Should Know

TriSalus Life Sciences reports 60% revenue growth in Q4 2025

TriSalus Life Sciences stock maintains Buy rating at Canaccord on strong growth